Quantification of the type 2 diabetes risk in women with gestational diabetes: a systematic review and meta-analysis of 95,750 women by unknown
Meta-Analysis
Quantification of the type 2 diabetes risk in women
with gestational diabetes: a systematic review and meta-analysis
of 95,750 women
Girish Rayanagoudar1 & Amal A. Hashi1 & Javier Zamora1,2,3 & Khalid S. Khan1,4 &
Graham A. Hitman1 & Shakila Thangaratinam1,4
Received: 21 November 2015 /Accepted: 25 February 2016 /Published online: 13 April 2016
# The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract
Aims/hypothesis Women with gestational diabetes mellitus
(GDM) are at risk of developing type 2 diabetes, but
individualised risk estimates are unknown. We conducted a
meta-analysis to quantify the risk of progression to type 2
diabetes for women with GDM.
Methods We systematically searched the major electronic
databases with no language restrictions. Two reviewers inde-
pendently extracted 2×2 tables for dichotomous data and the
means plus SEs for continuous data. Risk ratios were calcu-
lated and pooled using a random effects model.
Results There were 39 relevant studies (including 95,750
women) BMI (RR 1.95 [95% CI 1.60, 2.31]), family history
of diabetes (RR 1.70 [95% CI 1.47, 1.97]), non-white ethnic-
ity (RR 1.49 [95% CI 1.14, 1.94]) and advanced maternal age
(RR 1.20 [95% CI 1.09, 1.34]) were associated with future
risk of type 2 diabetes. There was an increase in risk with early
diagnosis of GDM (RR 2.13 [95% CI 1.52, 3.56]), raised
fasting glucose (RR 3.57 [95% CI 2.98, 4.04]), increased
HbA1c (RR 2.56 [95% CI 2.00, 3.17]) and use of insulin
(RR 3.66 [95% CI 2.78, 4.82]). Multiparity (RR 1.23 [95%
CI 1.01, 1.50]), hypertensive disorders in pregnancy (RR 1.38
[95% CI 1.32, 1.45]) and preterm delivery (RR 1.81 [95% CI
1.35, 2.43]) were associated with future diabetes. Gestational
weight gain, macrosomia in the offspring or breastfeeding did
not increase the risk.
Conclusions/interpretation Personalised risk of progression
to type 2 diabetes should be communicated to mothers with
GDM.
Systematic review registration: www.crd.york.ac.uk/
PROSPERO CRD42014013597
Keywords Gestational diabetes .Meta-analysis .
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Introduction
Gestational diabetes mellitus (GDM), defined as glucose in-
tolerance that is first diagnosed in pregnancy, is on the in-
crease worldwide [1]. Up to half of all women with this con-
dition progress to develop type 2 diabetes in later life, with the
highest occurrence rate in the first 5 years after pregnancy [2].
Increasing numbers of women are presenting with previously
undiagnosed diabetes and related complications, leading to
substantial healthcare costs [3].
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Current guidelines recommend following up women with
GDM to identify type 2 diabetes at an early stage [4]. Ensuring
compliance with this strategy is a significant global problem
[5–7]. Despite evidence that the future risk of type 2 diabetes
can be reduced by diet and lifestyle interventions and treat-
ment with drugs such as metformin, [8, 9], less than a fifth of
mothers with GDM undergo postpartum glucose screening
[10]. Personalised risk communication with quantitative esti-
mates can increase the number of individuals that make in-
formed choices in screening programmes [11]. However, few
prediction models for type 2 diabetes include GDM, and none
of them account for pregnancy-specific characteristics [12].
Gestation-specific factors such as glycaemic status in preg-
nancy, gestational weight gain and obstetric complications are
known to influence the future risk of diabetes [13–17]. Health-
care professionals involved in the management of women
with GDM do not provide individual risk estimates because
of the lack of data; this greatly hinders counselling. Existing
reviews have not quantified the risk of progression to type 2
diabetes [16, 18], and primary studies provide imprecise esti-
mates because of their relatively small sample size [19–21].
We therefore undertook a systematic review to assess the
strength of association of various maternal and pregnancy-
related factors with GDM with the future risk of type 2
diabetes.
Methods
We conducted a systematic review following a prospective
protocol in line with current recommendations, and complied
with the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) guidelines for reporting (see
electronic supplementary material [ESM] PRISMA checklist)
[22]. Ethical approval was not required.
Data sources and searchesWe searched the MEDLINE and
EMBASE databases (from inception until July 2015) for stud-
ies that assessed the risk factors in women with GDM and
progression to type 2 diabetes. We used keywords, Medical
Subject Headings and word variants for GDM such as ‘diabe-
tes, gestational’, ‘GDM’, and ‘pregnancy induced diabetes’,
and combined these with terms for type 2 diabetes such as
‘diabetes mellitus, type 2’, ‘NIDDM’ (i.e. non-insulin-
dependent diabetes mellitus), ‘adult-onset diabetes mellitus’
and ‘ketosis-resistant diabetes’ (See ESM Search strategy). We
searched the reference lists of identified papers for other relevant
studies. Authors of eligible studies were contacted for further
details if necessary. We did not apply any language restrictions.
Study selection Two independent reviewers (GR and AAH)
selected the studies. First, we reviewed the abstracts for po-
tentially relevant studies. Second, we obtained full copies of
all possibly eligible papers for detailed evaluation. We includ-
ed studies on women with GDM that assessed at least one of
the following factors: maternal characteristics such as age,
BMI, ethnicity, parity and family history of type 2 diabetes;
factors specific to pregnancy such as gestational age at GDM
diagnosis, antenatal OGTT, HbA1c, insulin use in pregnancy,
gestational weight gain, pregnancy-induced hypertension and
preterm delivery; and postpartum factors such as the baby’s
birthweight and breastfeeding. We excluded studies with no
relevant data, an inappropriate outcome, no original data (e.g.
meeting abstract, editorial, commentary or letter) or duplicate
data. We accepted the authors’ definitions of GDM and type 2
diabetes. Any discrepancies in selection were resolved by dis-
cussion with a third reviewer (ST).
Data extraction and quality assessment Two reviewers (GR
and AAH) independently undertook study quality assessment
and data extraction using predesigned forms. We used the
Newcastle–Ottawa scale [23], which evaluates the representa-
tiveness and selection of studies, comparability among co-
horts, ascertains the exposure and outcome, and evaluates
the length and adequacy of follow-up. The risk of bias was
considered to be low if a study obtained four stars for selec-
tion, two for comparability and three for follow-up; and me-
dium if a study scored two or three stars for selection, one for
comparability and two for follow-up. Studies scoring one or
zero stars for selection and follow-up, and with no star for
comparability, were deemed to have a high risk of bias [24].
Data were extracted as 2×2 tables for dichotomous outcomes,
and as means and SEs for continuous outcomes.
Data synthesis and analysis For various risk factors, we cal-
culated the RRs for dichotomous variables, and plotted point
estimates and 95% CIs for progression to type 2 diabetes for
women with GDM associated with various risk factors. For
continuous variables, we plotted pooledmean differenceswith
95% CIs to assess differences between women with and with-
out type 2 diabetes. We assessed the heterogeneity of associ-
ation graphically with forest plots and statistically with χ2
tests and the I2 statistic. We pooled results using random
effects models. To facilitate comparison between the strength
of association of various risk factors with type 2 diabetes, we
transformed the pooled standardised mean differences of
continuous outcomes into RRs, assuming a 20% baseline risk
of type 2 diabetes [25].
We specified the following subgroup analyses a priori:
length of follow-up (≤1 year vs >1 year), ethnicity (white vs
non-white), use of strict criteria to exclude possible pre-
existing type 2 diabetes (such as GDM before 20 weeks of
pregnancy or type 2 diabetes diagnosis in the first year after
delivery; yes vs no). Additionally, we investigated differences
between subgroups based on the levels of fasting glucose
criteria for diagnosing GDM (<5.8 mmol/l vs ≥5.8 mmol/l).
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All analyses were performed using the Review Manager
(RevMan Computer program, Version 5.2; The Nordic
Cochrane Centre, Copenhagen, Denmark) [26].
Results
Study identification From 5,966 citations, we selected 178
studies for further evaluation (Fig. 1). After a detailed assess-
ment, we included 39 studies (95,750 women) [13–15, 17,
19–21, 27–58]. We excluded 139 studies for the following
reasons: inclusion criteria were not met (n=65); presented as
posters, conference abstracts or letters (n=50); inappropriate
data format (n=15); only abstracts were available (n=4);
duplicate data (n=4); and could not be translated from the
language of publication (n=1).
Characteristics and quality of the included studies In all,
there were 22 prospective cohort studies (56%) [13, 14, 17,
19–21, 29, 32, 35–37, 39–41, 43, 44, 46–48, 50, 52, 55] and
17 retrospective cohort studies (44%) [15, 27, 28, 30, 31, 33,
34, 38, 42, 45, 49, 51, 53, 54, 56–58]. The studies evaluated
the association of maternal characteristics, pregnancy-specific
factors and postpartum characteristics with progression to type
2 diabetes in women with GDM. The studies varied in their
diagnostic criteria for both GDM and type 2 diabetes.
Maternal characteristics including BMI, ethnicity and family
history of diabetes were evaluated, as were risk factors specif-
ic to pregnancy such as maternal age at diagnosis of GDM,
parity, gestational age at diagnosis, weight gain in pregnancy,
hypertensive diseases in pregnancy and preterm birth, and
levels of fasting, post-load blood glucose levels during
OGTT, HbA1c in pregnancy and use of insulin for managing
GDM.
The duration of follow-up varied from 6 weeks to 20 years
after birth. A total of 29 studies (74%) evaluated the long-term
risk of type 2 diabetes (>1 year after delivery) and 10 (26%)
evaluated the risk of developing type 2 diabetes in the first
year after childbirth. Detailed characteristics of the included
studies are provided in ESM Table 1. In all, six studies (15%)
had a low risk of selection bias, 32 (82%) had a medium risk
and one (3%) had a high risk. Eight studies (21%) had a low
risk of bias for comparability of cohorts, and 31 (79%) had a
medium risk of bias. For outcome assessment, 11 studies
(28%) had a low risk of bias, 22 (56%) had a medium risk
and 6 (15%) had a high risk (see Fig. 2 and ESM Table 2).
Maternal characteristics and progression to type 2 diabetes
A high BMI doubled the risk of future type 2 diabetes (RR
1.95 [95% CI 1.60, 2.31]; I2 = 65%), and the risk was
Citations identified by 
electronic search (n=5,966) 
Studies evaluated in detail 
(n=178)
Studies excluded (n=139) 
 Did not meet inclusion criteria (n=65) 
 Posters, conference abstracts, letters 
(n=50) 
 Data in relative measures (n=15) 
 Unable to get full text (n=4) 
 Duplicate data (n=4)
 Unable to translate (n=1)
Studies included in the 
systematic review (n=39)
Total no. of women = 95,750
Studies excluded by title and 
abstract alone (n=5,801) 
Studies identified from 
reference lists (n=13) 
Fig. 1 Flow chart for study
selection for the systematic
review of the predictors of
progression to type 2 diabetes in
women with GDM
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increased in obese and overweight women for BMI thresholds
of 25 kg/m2 (RR 3.18 [95%CI 1.96, 5.16]; I2=77%), 27 kg/m2
(RR 2.52 [95% CI 1.69, 3.74]; I2=23%) and 30 kg/m2 (RR
2.85 [95% CI 2.21, 3.69]; I2=45%). A family history of diabe-
tes (RR 1.70 [95% CI 1.47, 1.97]; I2=13%), non-white ethnic-
ity (RR 1.49 [95% CI 1.14, 1.94]; I2=88%) and older age (RR
1.20 [95% CI 1.09, 1.34]; I2=0%) were found to be significant
risk factors for progression to diabetes after GDM. No
increased risk was observed for individual age cut-offs of 30
and 35 years (Fig. 3).
Pregnancy-specific factors and risk of future diabetes
Increased levels of fasting (RR 3.57; 95% CI 2.98, 4.04;
I2=90%), 1 h (RR 3.05; 95% CI 2.40, 3.63; I2=64%), 2 h
(RR 3.46; 95% CI 2.60, 4.10; I2=80%) and 3 h (RR 3.2;
95% CI 2.54, 3.75; I2= 65%) blood glucose levels after
OGTT and high HbA1c were associated with an increased risk
of future diabetes (RR 2.56; 95% CI 2.00, 3.17; I2=54%).
Women who required insulin to manage GDMwere more like-
ly to develop type 2 diabetes (RR 3.66 [95% CI 2.78, 4.82];
I2= 71%) compared with those managed without insulin
(Fig. 3).
Multiparity was a significant risk factor compared with
nulliparity (RR 1.23 [95% CI 1.01, 1.50]; I2=0%). Women
with pregnancy complications such as hypertensive disease
(RR 1.38 [95% CI 1.32, 1.45]; I2=0%) and preterm delivery
(<37 weeks) (RR 1.81 [95% CI 1.35, 2.43]; I2=0%) were
more likely to develop type 2 diabetes in the future. There
were no differences in gestational weight gain (mean differ-
ence −0.83 kg [95% CI −2.18, 0.51]; I2=65%) between the
two groups (ESM Fig. 1).
Delivery and postpartum factors The risk of developing
type 2 diabetes was not associated with birthweight (RR
1.19 [95% CI 0.86, 1.58]; I2=60%), fetal macrosomia (RR
0.91 [95% CI 0.44, 1.86]) or breastfeeding (RR 0.77 [95% CI
0.48, 1.22]; I2=9%).
Subgroup analysis There were significant between-group
differences based on follow-up time (<1 year vs >1 year) for
risk factors such as fasting glucose (p=0.04), BMI (p=0.03)
and insulin use (p=0.006) and type 2 diabetes. We did not
observe any between-group differences based on ethnicity and
GDM diagnostic criteria (fasting glucose level of <5.8 mmol/l
or ≥5.8 mmol/l) for predictors such as maternal age, BMI,
family history of diabetes, need for insulin in pregnancy and
the risk of type 2 diabetes. There was a significant difference
between subgroups based on strict criteria for excluding pos-
sible pre-existing type 2 diabetes for fasting glucose as a pre-
dictor of type 2 diabetes (p=0.02), but no differences were
observed for associations with other predictors (Table 1).
Discussion
Summary of findings The future risk of diabetes appears to
be mainly influenced by the gestational glycaemic status, and
not by the mother’s gestational weight gain or baby’s
birthweight. We found that both hypertensive disorders in
pregnancy and preterm delivery in GDM pregnancies were
associated with future onset of type 2 diabetes, which was
previously unknown. Factors specific to pregnancy such as
gestational age at onset of GDM and general maternal charac-
teristics such as BMI, ethnicity and family history were also
associated with future onset of type 2 diabetes. This system-
atic review has thus collated the information necessary for
postnatal counselling of women with GDM.
Strengths and limitations To our knowledge, this is the first
review to quantify the links between clinical characteristics
(especially those relevant to pregnancy) and the future onset
of diabetes in women with GDM. This systematic review used
a prospective protocol and a comprehensive search without any
language restrictions. Our meta-analysis included a large num-
ber of studies, and we were able to study most of the potentially
relevant risk factors. Previous reviews were limited in their find-
ings by the small number of studies included and the absence of
summary estimates [2, 16, 18, 59]. We have provided clinically
relevant estimates as RRs for use in counselling of women.
The studies included had varying definitions of population,
risk factors and methods of ascertaining the outcome, which
included different lengths of follow-up. Subgroup analysis
was planned a priori to identify any sources of heterogeneity.
It is possible that some studies could have misclassified pre-













Risk of bias (%)
Fig. 2 Risk of bias assessment on the Newcastle–Ottawa Scale for stud-
ies included in the systematic review of type 2 diabetes prediction in
women with GDM. Light grey bars, low risk; mid grey bars, medium
risk; dark grey bars, high risk. The numbers of studies are shown
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diagnosis was made as early as 6 weeks after delivery.
However, we did not observe significant between-group dif-
ferences based on strict criteria for excluding pre-existing type
2 diabetes (studies that excluded women with GDM diag-
nosed within 20 weeks’ gestation or diabetes in the first year
after delivery vs studies that did not). Some studies included
only diet-controlled GDM, and this may have underestimated
the risk of progression to type 2 diabetes.
The studies varied in the criteria used for diagnosing GDM
and in the thresholds for commencing insulin in pregnancy; a
third used Carpenter and Coustan criteria for diagnosing
GDM. Our subgroup analysis was based on a fasting glucose
cut-off value of 5.8 mmol/l: 69% of studies under this cut-off
used Carpenter and Coustan criteria, and showed no signifi-
cant differences in estimates for progression based on the
criteria used for GDM diagnosis. Despite these variations,
we consistently observed an increased risk of future diabetes
in women with gestational hyperglycaemia.
We evaluated associations of individual predictors with
outcomes, but could not adjust for confounding variables such
as BMI because of the lack of access to individual data. The
lack of detail in reported data made it difficult to evaluate the
simultaneous influence of multiple factors on outcome.
However, we could provide robust, precise estimates for indi-
vidual risk factors that are relevant for providing postnatal
information to women with GDM.
Comparison with existing evidence In the non-pregnant
state, BMI, family history of diabetes and ethnicity are associ-
ated with the risk of type 2 diabetes [18, 60–63]. We observed
the same in mothers with GDM, and there was a greater risk of
progression in non-white than in white women. Individual











Early GA at GDM diagnosis 8
Mean blood glucose (mmol/l) 
Fasting glucose 14
1 h glucose (100 g OGTT) 5
2 h glucose (100 g OGTT) 5
3 h glucose (100 g OGTT) 5
2 h glucose (75 g OGTT) 5
Mean HbA1c 6
Insulin use in pregnancy 24
Hypertension in pregnancy 3
Preterm delivery (<37 weeks) 3
Mean gestational weight gain 6
Multiparous vs nulliparous 6
Mean 6
No breast feeding 4
Birthweight
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Favours progression
to type 2 diabetes
10.1 0.2 0.5 2 5 10
Risk factor
Mean 1.20 (1.09, 1.34)17 6,549 0% <0.001
Parity
Fig. 3 Summary estimates for the association of maternal risk factors
with progression to type 2 diabetes in women with GDM. ‘Exclusively’
and ‘mostly’ breastfed were combined into a single breastfeeding catego-
ry. ‘Mixed or inconsistent’ breastfeeding and ‘exclusively or mostly for-
mula fed’ were combined into a single ‘no breastfeeding’ category [17].
Similarly, data reported for age <34 years in one study [37] was
categorised as age <35 years, and data reported as BMI of <28 kg/m2
for one study [50] was classified as a BMI of <27 kg/m2 because all other
studies used this cut-off value. GA, gestational age
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studies have shown that particular ethnic groups such as blacks
and South Asians are at an increased risk [15, 34]. Owing to the
various classifications of ethnicity used in primary studies, we
were unable to provide progression rates for specific ethnic
subgroups, which may have contributed to the heterogeneity.
We did not identify an increased risk for women with high
weight gain during pregnancy. However, it is likely that wom-
en with severe GDM undergo intensive monitoring and
receive significant input regarding their diet and lifestyles,
thereby restricting their weight gain in pregnancy [50].
Although previous studies have shown an improvement in
glucose homeostasis with breastfeeding [17, 64], we found no
significant association between the absence of breast-feeding
and progression to diabetes. This could be attributed to the
imprecise estimates obtained owing to the small number of
studies and individuals. Previous studies have shown
improved glucose values on OGTTs, especially in the short
term [64]. Our review measured the impact on type 2 diabetes
and not on lesser degrees of glucose intolerance. Furthermore,
the beneficial effect on glucose levels may not have been
sustained in the long term. The rigour with which breast-
feeding information was collected also varied by study; most
data were self-reported by the women.
In current practice, the criteria used for diagnosing GDM are
not applicable in many centres. However, given the long-term
outcomes evaluated in our review, we were unable to assess for
heterogeneity in estimates based on the WHO 2013 criteria for
diagnosing GDM [65], which are recommended in many
existing national and international guidelines.
Implications for clinical practice Pregnancy is an important
point in the life of a woman when she has regular contact with
the healthcare system, thus providing opportunities to influence
the future health of both mother and child. One of the major
factors responsible for poor postnatal screening for diabetes and
subsequent follow-up has been the lack of clear communication
between secondary and primary care providers [10, 66].
Pregnancy-specific findings such as glycaemic control, despite
being associated with a fourfold increase in the risk of future
diabetes, are not taken into count during counselling.
Postnatal advice to women with GDM should incorporate
information on their individual risk factors. Communication
between hospitals and general practitioners on the mother’s risk
of future diabetes could be improved by providing discharge
summaries with pregnancy-specific details such as OGTT
results, gestational age at GDM diagnosis, use of insulin, and
complications such as pre-eclampsia and preterm birth. An
efficient system of data linkage and communication between
secondary and primary care providers will enable general prac-
titioners to incorporate this information into their management
of mothers; in particular, the management of women at a high-
risk of developing type 2 diabetes could involve measures such
as reminder systems [67]. Women are more likely to comply
with diet and lifestyle changes if they know their individual
risks of future diabetes [68].
Research recommendations Current prediction models for
type 2 diabetes should be updated and validated by including
the factors identified in this review. There is a need for well-
designed, prospective long-term studies to explore the associ-
ation between breastfeeding and future type 2 diabetes [64].
The meta-analysis of individual participant data (IPD) could
overcomemany of the limitations of our meta-analysis [69]. A
large-scale IPD meta-analysis could enable us to predefine the
desired clinically relevant endpoints (e.g. timing of diabetes
onset) and cut-off values for clinical variables, standardise the
definitions of predictors and outcomes, take into account the
performance of many candidate prognostic variables, directly
handle missing data on both predictors and outcomes, and
account for heterogeneity in baseline risks.
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a Diagnosis of GDM before 20 weeks of gestation or type 2 diabetes less than 1 year after delivery
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Conclusion Postnatal counselling of women with GDM
should be individualised for the risk of future diabetes.
Funding This independent research was funded by European Union’s
Seventh Framework Programme under EC-GA No. 278917 (GIFTS
‘Genomic and lifestyle predictors of fetal outcome relevant to diabetes
and obesity and their relevance to prevention strategies in South Asian
peoples’). The funding body played no role in designing or conducting
the study or preparing the report.
Duality of interest statement All authors completed the International
Committee of Medical Journal Editors (ICMJE) uniform disclosure form
(www.icmje.org/coi_disclosure.pdf) and declare that they have received
no support from any organisation for the submitted work, have had no
financial relationship over the last 3 years with any organisation that
might have an interest in the submitted work, and have no other
relationships or activities that could influence the submitted work.
Contribution statement GAH and KSK contributed to the study de-
sign; GR and ST designed the protocol; AAH and GR selected eligible
studies; GR developed the data extraction form; AAH and GR extracted
the data; ST resolved discrepancies between reviewers on text selection
and data extraction; GR, JZ and STwrote the statistical analysis plan; GR
cleaned and analysed the data; GR drafted the paper, AAH, GAH, JZ,
KSK and ST revised the manuscript; and SToversaw the conduct of study
at all stages. All authors read and approved the final draft before submis-
sion. GR is the guarantor of this work.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
1. Galtier F (2010) Definition, epidemiology, risk factors. Diabetes
Metab 36:628–651
2. Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2
diabetes mellitus after gestational diabetes: a systematic review and
meta-analysis. Lancet 373:1773–1779
3. Hex N, Bartlett C,Wright D, Taylor M, Varley D (2012) Estimating
the current and future costs of Type 1 and Type 2 diabetes in the
UK, including direct health costs and indirect societal and produc-
tivity costs. Diabet Med 29:855–862
4. National Institute for Health and Care Excellence (2008) Diabetes
in pregnancy: management of diabetes and its complications from
preconception to the postnatal period. Clinical Guideline 63.
National Institute for Health and Care Excellence, London
5. Almario CV, Ecker T, Moroz LA, Bucovetsky L, Berghella V,
Baxter JK (2008) Obstetricians seldom provide postpartum diabe-
tes screening for women with gestational diabetes. Am J Obstet
Gynecol 198(528):e521–e525
6. Ferrara A, Peng T, Kim C (2009) Trends in postpartum diabetes
screening and subsequent diabetes and impaired fasting glucose
among women with histories of gestational diabetes mellitus: a
report from the Translating Research Into Action for Diabetes
(TRIAD) Study. Diabetes Care 32:269–274
7. Baker AM, Brody SC, Salisbury K, Schectman R, Hartmann KE
(2009) Postpartum glucose tolerance screening in women with ges-
tational diabetes in the state of North Carolina. N CMed J 70:14–19
8. Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction
in the incidence of type 2 diabetes with lifestyle intervention or
metformin. N Engl J Med 346:393–403
9. Ratner RE, Christophi CA, Metzger BE et al (2008) Prevention of
diabetes in women with a history of gestational diabetes: effects of
metformin and lifestyle interventions. J Clin Endocrinol Metab 93:
4774–4779
10. McGovern A, Butler L, Jones S et al (2014) Diabetes screening
after gestational diabetes in England: a quantitative retrospective
cohort study. Br J Gen Pract 64:e17–e23
11. Edwards AG, Naik G, Ahmed H, et al (2013) Personalised risk
communication for informed decision making about taking screen-
ing tests. Cochrane Database Syst Rev (2):CD001865. doi:10.1002/
14651858.CD001865.pub3
12. Kengne AP, Beulens JW, Peelen LM et al (2014) Non-invasive risk
scores for prediction of type 2 diabetes (EPIC-InterAct): a valida-
tion of existing models. Lancet Diabetes Endocrinol 2:19–29
13. Kwak SH, Choi SH, Jung HS et al (2013) Clinical and genetic risk
factors for type 2 diabetes at early or late post partum after gesta-
tional diabetes mellitus. J Clin Endocrinol Metab 98:E744–E752
14. Gobl CS, Bozkurt L, Prikoszovich T, Winzer C, Pacini G, Kautzky-
Willer A (2011) Early possible risk factors for overt diabetes after
gestational diabetes mellitus. Obstet Gynecol 118:71–78
15. Wang Y, Chen L, Horswell R et al (2012) Racial differences in the
association between gestational diabetes mellitus and risk of type 2
diabetes. J Womens Health (Larchmt) 21:628–633
16. Golden SH, Bennett WL, Baptist-Roberts K et al (2009)
Antepartum glucose tolerance test results as predictors of type 2
diabetes mellitus in women with a history of gestational diabetes
mellitus: a systematic review. Gend Med 6(Suppl 1):109–122
17. Gunderson EP, Hedderson MM, Chiang V et al (2012) Lactation
intensity and postpartum maternal glucose tolerance and insulin
resistance in women with recent GDM: the SWIFT cohort.
Diabetes Care 35:50–56
18. Baptiste-Roberts K, Barone BB, Gary TL et al (2009) Risk factors
for type 2 diabetes among women with gestational diabetes: a sys-
tematic review. Am J Med 122:207–214.e204
19. Cheung NW, Helmink D (2006) Gestational diabetes: the signifi-
cance of persistent fasting hyperglycemia for the subsequent devel-
opment of diabetes mellitus. J Diabetes Complicat 20:21–25
20. OldfieldMD, Donley P,Walwyn L, Scudamore I, Gregory R (2007)
Long term prognosis of women with gestational diabetes in a mul-
tiethnic population. Postgrad Med J 83:426–430
21. Tura A, Grassi A, Winhofer Y et al (2012) Progression to type 2
diabetes in women with former gestational diabetes: time trajecto-
ries of metabolic parameters. PLoS One 7:e50419
22. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred
reporting items for systematic reviews and meta-analyses: the
PRISMA statement. BMJ (Clin Res Ed) 339:b2535
23. Wells G, Shea B, O’Connell D et al The Newcastle-Ottawa Scale
(NOS) for assessing the quality of nonrandomized studies in meta-
analysis. Available from www.ohri.ca/programs/clinical_
epidemiology/oxford.asp, accessed 20 Sept 2014
24. Wilson A, Lissauer D, Thangaratinam S, Khan KS, MacArthur C,
Coomarasamy A (2011) A comparison of clinical officers with
medical doctors on outcomes of caesarean section in the developing
world: meta-analysis of controlled studies. BMJ (Clin Res Ed) 342:
d2600
25. Chinn S (2000) A simple method for converting an odds ratio to
effect size for use in meta-analysis. Stat Med 19:3127–3131
26. Cochrane (2012) Review Manager (RevMan) version 5.2. The
Nordic Cochrane Centre, Copenhagen
27. Lin PC, Hung CH, Huang RD, Chan TF (2015) Predictors of type 2
diabetes among Taiwanese women with prior gestational diabetes
mellitus. Jpn J Nurs Sci 13:3–9
Diabetologia (2016) 59:1403–1411 1409
28. Eades CE, Styles M, Leese GP, Cheyne H, Evans JM (2015)
Progression from gestational diabetes to type 2 diabetes in one
region of Scotland: an observational follow-up study. BMC
Pregnancy Childbirth 15:11
29. Bao W, Yeung E, Tobias DK et al (2015) Long-term risk of type 2
diabetes mellitus in relation to BMI and weight change among
women with a history of gestational diabetes mellitus: a prospective
cohort study. Diabetologia 58:1212–1219
30. Carvalho Ribeiro AM, Nogueira-Silva C, Melo-Rocha G, Pereira
ML, Rocha A (2015) Gestational diabetes: determination of risk
factors to diabetes mellitus. Rev Port Endocrinol Diabetes Metab
10:8–13 [article in Portuguese]
31. Feig DS, Shah BR, Lipscombe LL et al (2013) Preeclampsia as a
risk factor for diabetes: a population-based cohort study. PLoSMed
10:e1001425
32. Chew WF, Rokiah P, Chan SP, Chee WSS, Lee LF, Chan YM
(2012) Prevalence of glucose intolerance, and associated antenatal
and historical risk factors among Malaysian women with a history
of gestational diabetes mellitus. Singap Med J 53:814–820
33. Mukerji G, Chiu M, Shah BR (2012) Impact of gestational diabetes
on the risk of diabetes following pregnancy among Chinese and
South Asian women. Diabetologia 55:2148–2153
34. Xiang AH, Li BH, Black MH et al (2011) Racial and ethnic dispar-
ities in diabetes risk after gestational diabetes mellitus. Diabetologia
54:3016–3021
35. Ekelund M, Shaat N, Almgren P, Groop L, Berntorp K (2010)
Prediction of postpartum diabetes in women with gestational dia-
betes mellitus. Diabetologia 53:452–457
36. Ogonowski J, Miazgowski T (2009) The prevalence of 6 weeks
postpartum abnormal glucose tolerance in Caucasian women with
gestational diabetes. Diabetes Res Clin Pract 84:239–244
37. Hossein-nezhad A, Mirzaei K, Maghbooli Z, Larijani B (2009)
Maternal glycemic status in GDM patients after delivery. Iran J
Diabetes Lipid Disord 8:95–104
38. Russell C, Dodds L, Armson BA, Kephart G, Joseph KS (2008)
Diabetes mellitus following gestational diabetes: role of subsequent
pregnancy. BJOG 115:253–259
39. Rivero K, Portal VL, Vieira M, Behle I (2008) Prevalence of the
impaired glucose metabolism and its association with risk factors
for coronary artery disease in women with gestational diabetes.
Diabetes Res Clin Pract 79:433–437
40. Krishnaveni GV, Hill JC, Veena SR et al (2007) Gestational diabetes
and the incidence of diabetes in the 5 years following the index preg-
nancy in South Indian women. Diabetes Res Clin Pract 78:398–404
41. Zonenberg A, Telejko B, Topolska J et al (2006) Factors predispos-
ing to disturbed carbohydrate tolerance in patients with previous
gestational diabetes mellitus. Diabetol Dosw Klin 6:143–150
42. Weijers RNM, Bekedam DJ, Goldschmidt HMJ, Smulders YM
(2006) The clinical usefulness of glucose tolerance testing in ges-
tational diabetes to predict early postpartum diabetes mellitus. Clin
Chem Lab Med 44:99–104
43. Kousta E, Efstathiadou Z, Lawrence NJ et al (2006) The impact of
ethnicity on glucose regulation and the metabolic syndrome follow-
ing gestational diabetes. Diabetologia 49:36–40
44. Kim SH, Kim MY, Yang JH et al (2011) Nutritional risk factors of
early development of postpartum prediabetes and diabetes in wom-
en with gestational diabetes mellitus. Nutrition 27:782–788
45. Jarvela IY, Juutinen J, Koskela P et al (2006) Gestational diabetes
identifies women at risk for permanent type 1 and type 2 diabetes in
fertile age: predictive role of autoantibodies. Diabetes Care 29:607–612
46. Hunger-Dathe W, Mosebach N, Samann A, Wolf G, Muller UA
(2006) Prevalence of impaired glucose tolerance 6 years after ges-
tational diabetes. Exp Clin Endocrinol Diabetes 114:11–17
47. Cho NH, Jang HC, Park HK, Cho YW (2006) Waist circumference
is the key risk factor for diabetes in Korean women with history of
gestational diabetes. Diabetes Res Clin Pract 71:177–183
48. Lin CH, Wen SF, Wu YH, Huang YY, Huang MJ (2005) The
postpartummetabolic outcome of women with previous gestational
diabetes mellitus. Chang Gung Med J 28:794–800
49. Schaefer-Graf UM, Buchanan TA, Xiang AH, Peters RK, Kjos
SL (2002) Clinical predictors for a high risk for the develop-
ment of diabetes mellitus in the early puerperium in women
with recent gestational diabetes mellitus. Am J Obstet Gynecol
186:751–756
50. Dalfra MG, Lapolla A, Masin M et al (2001) Antepartum and early
postpartum predictors of type 2 diabetes development in women
with gestational diabetes mellitus. Diabetes Metab 27:675–680
51. Pallardo F, Herranz L, Garcia-Ingelmo T et al (1999) Early postpar-
tummetabolic assessment in womenwith prior gestational diabetes.
Diabetes Care 22:1053–1058
52. Buchanan TA, Xiang AH, Kjos SL, Trigo E, Lee WP, Peters RK
(1999) Antepartum predictors of the development of type 2 diabetes
in Latino women 11–26 months after pregnancies complicated by
gestational diabetes. Diabetes 48:2430–2436
53. Steinhart JR, Sugarman JR, Connell FA (1997) Gestational diabetes
is a herald of NIDDM in Navajo women. High rate of abnormal
glucose tolerance after GDM. Diabetes Care 20:943–947
54. Greenberg LR, Moore TR, Murphy H (1995) Gestational diabetes
mellitus: antenatal variables as predictors of postpartum glucose
intolerance. Obstet Gynecol 86:97–101
55. Damm P, Kuhl C, Bertelsen A, Molsted-Pedersen L (1992) Predictive
factors for the development of diabetes in women with previous ges-
tational diabetes mellitus. Am J Obstet Gynecol 167:607–616
56. Liu H, Zhang C, Zhang S et al (2014) Prepregnancy body mass
index and weight change on postpartum diabetes risk among ges-
tational diabetes women. Obesity 22:1560–1567
57. Capula C, Chiefari E, Vero A, Foti DP, Brunetti A, Vero R (2014)
Prevalence and predictors of postpartum glucose intolerance in
Italian women with gestational diabetes mellitus. Diabetes Res
Clin Pract 105:223–230
58. Bentley-Lewis R, Dawson DL, Wenger JB, Thadhani RI,
Roberts DJ (2014) Placental histomorphometry in gestational
diabetes mellitus: the relationship between subsequent type 2
diabetes mellitus and race/ethnicity. Am J Clin Pathol 141:
587–592
59. Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and
the incidence of type 2 diabetes: a systematic review. Diabetes Care
25:1862–1868
60. Garber AJ (2012) Obesity and type 2 diabetes: which patients are at
risk? Diabetes Obes Metab14:399–408
61. Bakker LE, Sleddering MA, Schoones JW, Meinders AE, Jazet IM
(2013) Pathogenesis of type 2 diabetes in South Asians. Eur J
Endocrinol 169:R99–R114
62. Meigs JB, Cupples LA,Wilson PW (2000) Parental transmission of
type 2 diabetes: the Framingham Offspring Study. Diabetes 49:
2201–2207
63. Chan JC, Malik V, Jia W et al (2009) Diabetes in Asia: epidemiol-
ogy, risk factors, and pathophysiology. JAMA 301:2129–2140
64. Much D, Beyerlein A, Rossbauer M, Hummel S, Ziegler AG
(2014) Beneficial effects of breastfeeding in women with gestation-
al diabetes mellitus. Mol Metab 3:284–292
65. WHO (2013) Diagnostic Criteria and Classification of
Hyperglycaemia First Detected in Pregnancy. World Health
Organization, Geneva
66. Pierce M, Modder J, Mortagy I, Springett A, Hughes H, Baldeweg
S (2011) Missed opportunities for diabetes prevention: post-
pregnancy follow-up of women with gestational diabetes mellitus
in England. Br J Gen Pract 61:e611–e619
67. Middleton P, Crowther CA (2014) Reminder systems for womenwith
previous gestational diabetes mellitus to increase uptake of testing for
type 2 diabetes or impaired glucose tolerance. CochraneDatabase Syst
Rev (3):CD009578. doi: 10.1002/14651858.CD009578.pub2
1410 Diabetologia (2016) 59:1403–1411
68. Kim C, McEwen LN, Piette JD, Goewey J, Ferrara A,
Walker EA (2007) Risk perception for diabetes among wom-
en with histories of gestational diabetes mellitus. Diabetes
Care 30:2281–2286
69. Lambert PC, Sutton AJ, Abrams KR, Jones DR (2002) A com-
parison of summary patient-level covariates in meta-regression
with individual patient data meta-analysis. J Clin Epidemiol
55:86–94
Diabetologia (2016) 59:1403–1411 1411
